AZ sells rights to statin med Crestor to Grünenthal
Grünenthal will pay $320m upfront for the rights
Read Moreby Lucy Parsons | Dec 1, 2020 | News | 0
Grünenthal will pay $320m upfront for the rights
Read Moreby Selina McKee | Jan 8, 2018 | News | 0
New research part funded by the British Heart Foundation has highlighted stark inequalities between the treatment of men and women with heart attack and the effect this is having on survival.
Read Moreby Selina McKee | Oct 25, 2017 | News | 0
The majority of patients at high risk of cardiovascular disease are not being started on statin therapy, suggests new research published in the British Journal of General Practice.
Read Moreby Selina McKee | May 9, 2017 | News | 0
Researchers have kicked off a £6 million trial investigating the potential of simvastatin as a treatment for multiple sclerosis.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
